For the first time, researchers at King's College London and the University of Florence have identified the specific genetic ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Trisha Suppes, MD, ...

Topline data expected in 1Q 2028Phase 2bipolar depression trial initiation follows positive Phase 2 results in acute schizophreniaNEW YORK, Jan.

Most psychotherapy, whether short-term problem focused or long-term psychoanalytically-oriented treatment, relies upon a dialogue between the therapist and the patient. The purpose of this dialogue is ...

Cariprazine is an oral atypical antipsychotic that has emerged as a promising treatment option for both schizophrenia and bipolar disorder. It exerts its therapeutic effects primarily through partial ...

A potential new treatment for bipolar disorder (BP) that significantly shortens treatment time has emerged, following a randomized clinical trial using accelerated intermittent theta burst stimulation ...

Dr. Calabrese answers the question: 'When Can I Stop Taking Bipolar Meds?' — -- Question: How long do I have to take medication for bipolar disorder, and can I stop if I no longer have symptoms?

SAN MATEO, Calif.--(BUSINESS WIRE)--Baszucki Group today announced the launch of two new initiatives across multiple sites exploring the effectiveness of ketogenic therapy for children and adolescents ...

Researchers at King's College London and the University of Florence have, for the first time, identified the specific genetic ...